Salinomycin Suppresses PDGFRβ, MYC, and Notch Signaling in Human Medulloblastoma

Shuang Zhou1, Fengfei Wang1, Ying Zhang1

  • 1Department of Pharmaceutical Sciences, North Dakota State University, USA.

Austin Journal of Pharmacology and Therapeutics
|December 6, 2014
PubMed

Insights

Salinomycin effectively combats medulloblastoma (MB), the most common childhood brain tumor. This compound inhibits MB cell growth, triggers cell death, and alters cell cycle progression, offering a promising new therapeutic avenue.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Medulloblastoma (MB) is the most prevalent pediatric brain tumor.
  • Current treatments have limitations, with a significant mortality rate of approximately 30%.

Purpose of the Study:

  • To investigate the therapeutic potential of salinomycin against human MB cell lines.
  • To evaluate salinomycin's effects on MB cell proliferation, cell death, and cell cycle progression.

Main Methods:

  • Treatment of human MB cell lines with salinomycin.
  • Assessment of cell proliferation, cell death, and cell cycle distribution.
  • Analysis of gene expression changes related to proliferation and survival signaling pathways.

Main Results:

  • Salinomycin significantly inhibited MB cell proliferation and induced cell death.
  • Salinomycin disrupted normal cell cycle progression in MB cells.
  • Key gene expression changes included down-regulation of PDGFRβ, MYC, p21, Bcl-2, Hes1, and Hes5, and up-regulation of cyclin A.

Conclusions:

  • Salinomycin demonstrates potent anti-cancer activity in medulloblastoma models.
  • The drug affects critical pathways regulating cell growth and survival.
  • Salinomycin shows promise as a novel therapeutic agent for MB patients.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K